Lim, A. G., Aas, C. F., Çağlar, E. S., Vold, J. H., Fadnes, L. T., Vickerman, P., & Johansson, K. A. (2023). Cost‐effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO‐HCV trial. Addiction, 118(12), 2424. https://doi.org/10.1111/add.16305
Chicago Style (17th ed.) CitationLim, Aaron Guanliang, Christer Frode Aas, Ege Su Çağlar, Jørn Henrik Vold, Lars Thore Fadnes, Peter Vickerman, and Kjell Arne Johansson. "Cost‐effectiveness of Integrated Treatment for Hepatitis C Virus (HCV) Among People Who Inject Drugs in Norway: An Economic Evaluation of the INTRO‐HCV Trial." Addiction 118, no. 12 (2023): 2424. https://doi.org/10.1111/add.16305.
MLA (9th ed.) CitationLim, Aaron Guanliang, et al. "Cost‐effectiveness of Integrated Treatment for Hepatitis C Virus (HCV) Among People Who Inject Drugs in Norway: An Economic Evaluation of the INTRO‐HCV Trial." Addiction, vol. 118, no. 12, 2023, p. 2424, https://doi.org/10.1111/add.16305.